Tazarotene
Pricing Report NDC 60758-561-30

Latest NADAC: $1.47259 per GM · Effective Jul 17, 2024 · Est. package price $44.18 (30 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Tazarotene (NDC 60758-561-30) is $1.47259 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2024.

As a provided by Pacific Pharma, Inc., this medication is distributed in a 1 TUBE in 1 CARTON / 30 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.47259
Per GM

Effective Date
Jul 17, 2024
Billable Units
30 GM
Estimated Package Price
$44.18
Data Status
As of Aug 14, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2017, the NADAC wholesale price for (NDC ) has moved within a range of $1.47259 to $9.17050 per GM. Over this 7 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.4726 - $9.1705
Market Volatility
522.75% Variance
Latest Trend
1.16%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 23, 2024 $1.90901 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 18, 2024 $1.93145 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 21, 2024 $1.95596 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 17, 2024 $1.47259 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 17, 2024 $1.94799 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 19, 2024 $2.03122 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 19, 2024 $2.03392 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 22, 2024 $1.96625 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 22, 2024 $1.63010 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 17, 2024 $1.73748 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 17, 2024 $1.98810 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 20, 2024 $2.44783 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026